Low serum cholesterol and serotonin metabolism

BMJ

Volumn 312, Issue 7041, 1996, Pages 1298-

  Pijl, Hanno ^a   Toornvliet, Arnoud C ^a   Meinders, A Edo ^a   Leuven, Jan A Gevers ^a   Van Kempen, G M J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; SEROTONIN;

ALCOHOL CONSUMPTION; CHOLESTEROL BLOOD LEVEL; HUMAN; LETTER; MALE; METABOLISM; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONIN UPTAKE; THROMBOCYTE; THROMBOCYTE ACTIVATION; BLOOD; EPIDEMIOLOGY; NOTE;

CHOLESTEROL; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; MALE; SEROTONIN;

EID: 85007738458     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7041.1298b     Document Type: Letter

References (5)

1. Steegmans PHA, Fekkes D, Hoes AW, Bak AAA, van der Does E, Grobbee DE. Low serum cholesterol concentration and serotonin metabolism in men. BMJ 1996; 312: 221. (27 January.)
2. Linjaerde O. Inhibitory effect of ethanol on 5-hydroxytryptamine (serotonin) uptake in human blood platelets in vitro. Acta Pharmacol Toxicol 1979; 45: 394–398.
3. Barradas MA, Gill DS, Fonseca VA, Mikhailidis DP, Dandona P. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest 1988; 18: 399–404.
4. Tyce GM. Origin and metabolism of serotonin. J Cardiovasc Pharmacol 1990; 16: S1–S7.
5. Verbeuren TJ. 5-Hydroxytryptamine: distribution, synthesis, metabolism, release, uptake and passage across body membranes in cardiovascular tissues, including blood brain barrier. In: OlesenJ,SaxenaPR, eds. 5-Hydroxytryptamine mechanisms in primary headache. New York: Raven Press, 1992: 29–39.